Daniel Davis's team tests reengineered antibodies against cancer

4 articles · Updated · WIRED · Apr 30

Speaking at WIRED Health, the Imperial College London immunologist said work with Bristol Myers Squibb uses advanced microscopes to study nanoscale immune-cell interactions.
The Y-shaped antibodies are designed to bridge immune and cancer cells, cluster key proteins and deliver stronger kill signals, though Davis said the research remains early stage.
He said the findings could eventually inform patient trials and other immune therapies, while warning that personalised immune-health treatment is still distant and simplistic health claims deserve scepticism.

Can new microscopic discoveries make personalized cancer cures accessible and affordable for everyone?

Can we now reprogram immune cells inside our bodies to cure cancer, and what does this mean for medicine?

With our immune systems being so unique, is all 'one-size-fits-all' health advice now officially obsolete?